|
|
Line 13: |
Line 13: |
|
| |
|
| ===World Health Organization EURO Office=== | | ===World Health Organization EURO Office=== |
| *[https://www.euro.who.int/%20data/assets/pdf%20file/0009/443673/Electronic-nicotine-and-non-nicotine-delivery-systems-brief-eng.pdf Source] | | *[https://web.archive.org/web/20221120055000/https://www.euro.who.int/__data/assets/pdf_file/0009/443673/Electronic-nicotine-and-non-nicotine-delivery-systems-brief-eng.pdf Source] |
| [[file:INT WHO Euro.png|center]] | | [[file:INT WHO Euro.png|center]] |
| <br> | | <br> |
Line 22: |
Line 22: |
| <br> | | <br> |
|
| |
|
| ==European Parliament== | | ===European Parliament=== |
| *[https://web.archive.org/web/20221120055449/https://www.europarl.europa.eu/doceo/document/A-9-2022-0001_EN.html Source] | | *[https://web.archive.org/web/20221120055449/https://www.europarl.europa.eu/doceo/document/A-9-2022-0001_EN.html Source] |
| [[file:INT Eu Parliament.png|center]] | | [[file:INT Eu Parliament.png|center]] |
| <br> | | <br> |
|
| |
|
| ==SCENIHR - European Commission Directorate-General, Health & Consumer Protection== | | ===SCENIHR - European Commission Directorate-General, Health & Consumer Protection=== |
| [https://web.archive.org/web/20080302215712/https://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_013.pdf Source] | | *[https://web.archive.org/web/20080302215712/https://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_013.pdf Source] |
| [[file:SCENIHR.jpg|center]] | | [[file:SCENIHR.jpg|center]] |
| <br> | | <br> |
|
| |
|
| ==Cochrane systematic evidence review== | | ===Cochrane systematic evidence review=== |
| *[https://web.archive.org/web/20221120061056/https://www.cochrane.org/CD010216/TOBACCO_can-electronic-cigarettes-help-people-stop-smoking-and-do-they-have-any-unwanted-effects-when-used Source] | | *[https://web.archive.org/web/20221120061056/https://www.cochrane.org/CD010216/TOBACCO_can-electronic-cigarettes-help-people-stop-smoking-and-do-they-have-any-unwanted-effects-when-used Source] |
| *78 scientific studies (including >34 randomized control trials) involving 22,052 participants in a dozen countries. This 2022 update replaces their 2021 evidence review, based on 61 studies, which found “moderate certainty evidence.” | | *78 scientific studies (including >34 randomized control trials) involving 22,052 participants in a dozen countries. This 2022 update replaces their 2021 evidence review, based on 61 studies, which found “moderate certainty evidence.” |
Line 38: |
Line 38: |
| <br> | | <br> |
|
| |
|
| ==15 past presidents of the Society for Research on Nicotine and Tobacco (SRNT)== | | ===15 past presidents of the Society for Research on Nicotine and Tobacco (SRNT)=== |
| *[https://web.archive.org/web/20221120061557/https://ajph.aphapublications.org/doi/full/10.2105/AJPH.2021.306416 Source] | | *[https://web.archive.org/web/20221120061557/https://ajph.aphapublications.org/doi/full/10.2105/AJPH.2021.306416 Source] |
| *'''NOTE: This is not a statement by the SRNT.''' | | *'''NOTE: This is not a statement by the SRNT.''' |
Line 44: |
Line 44: |
| <br> | | <br> |
|
| |
|
| ==The Tobacco Atlas== | | ===The Tobacco Atlas=== |
| *The Tobacco Atlas is a collaborative publication by Vital Strategies & [https://tobacconomics.org/about-us/what-we-do/ Tobacconomics] at the Institute for Health Research and Policy. | | *The Tobacco Atlas is a collaborative publication by Vital Strategies & [https://tobacconomics.org/about-us/what-we-do/ Tobacconomics] at the Institute for Health Research and Policy. |
| *[https://www.vitalstrategies.org/about-us/ Vital Strategies] was formed out of a merger between World Lung Foundation and The Union. | | *[https://www.vitalstrategies.org/about-us/ Vital Strategies] was formed out of a merger between World Lung Foundation and The Union. |